ClinicalTrials.Veeva

Menu

Neural Correlates of Stress Hormones (Cort-fMRI)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Borderline Personality Disorder
PTSD

Treatments

Drug: Placebo
Drug: Hydrocortisone

Study type

Interventional

Funder types

Other

Identifiers

NCT02523664
WI-3396-2

Details and patient eligibility

About

To investigate which neuronal correlates underlie cortisol-induced enhancement of memory retrieval in PTSD and BPD.

Full description

The investigators have recently shown that hydrocortisone enhances rather than impairs memory retrieval in patients with posttraumatic stress disorder (PTSD) and borderline personality disorder (BPD). In contrast, in healthy participants memory retrieval was impaired after hydrocortisone compared to placebo.

The proposed studies aim to further investigate these findings and to understand the underlying neuronal correlates. Thus, the mechanisms of enhanced memory retrieval after hydrocortisone in patients with BPD and PTSD will be investigated by fMRI.

In a placebo-controlled study, the effects of 10mg hydrocortisone on brain activity, in particular the hippocampus, will be investigated in patients with PTSD and BPD and will be compared with those in healthy control participants. During the fMRI session, a declarative memory task (retrieval of a previous learned word list) and an autobiographical memory test will be performed. Effects of hydrocortisone on resting state brain activity and the neuronal correlates of memory retrieval will be analysed.

Enrollment

78 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Borderline Personality Disorder
  • Clinical diagnosis of PTSD
  • females without psychiatric disorders as control group
  • right handed

Exclusion criteria

  • fMRI exclusion criteria e.g. metal implants, pregnancy, left-handedness, and claustrophobia.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

78 participants in 2 patient groups, including a placebo group

Hydrocortisone
Active Comparator group
Description:
10 mg hydrocortisone orally
Treatment:
Drug: Hydrocortisone
Placebo
Placebo Comparator group
Description:
placebo orally
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems